HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

GBA variation and susceptibility to multiple system atrophy.

AbstractINTRODUCTION:
Genetic variants in the glucocerebrosidase (GBA) gene have been previously associated with susceptibility to synucleinopathies. The risk is well-established in Lewy body disease but is not as confirmed for multiple system atrophy (MSA). We aim to evaluate associations between exonic variants in GBA and risk of neuropathologically-confirmed multiple system atrophy (MSA).
METHODS:
Sanger gene sequencing of GBA was performed on 167 pathologically confirmed MSA patients collected at Mayo Clinic Florida Brain Bank, and data were extracted from whole-genome sequencing of 834 clinical controls. Common GBA variants were assessed for association with MSA. Rare GBA variants (and also all GBA variants) were collapsed together and evaluated for association with MSA risk using a gene-burden test.
RESULTS:
A total of 17 exonic GBA variants were observed, including a novel p.Q112X variant that is likely pathogenic in a patient with mixed parkinsonism-cerebellar subtype MSA. The more common p.N409S and p.L483P variants that recessively cause Gaucher's disease (GD), and are associated with risk of Lewy body disease, were not observed. When collapsing across all GBA variants, the presence of any GBA variant was significantly more frequent in MSA patients than in controls (OR = 1.90, P = 0.031). However, this association was driven by p.T408M, which had a significantly higher frequency in MSA patients compared to controls (OR = 4.21, P = 0.002). There was no significant association with risk of MSA for the p.E365K variant (OR = 0.79, P = 0.72).
CONCLUSIONS:
Other than the specific GBA p.T408M variant, coding GBA variants are not associated with risk of MSA.
AuthorsAnna I Wernick, Ronald L Walton, Shunsuke Koga, Alexandra I Soto-Beasley, Michael G Heckman, Ziv Gan-Or, Yingxue Ren, Rosa Rademakers, Ryan J Uitti, Zbigniew K Wszolek, William P Cheshire, Dennis W Dickson, Owen A Ross
JournalParkinsonism & related disorders (Parkinsonism Relat Disord) Vol. 77 Pg. 64-69 (08 2020) ISSN: 1873-5126 [Electronic] England
PMID32623306 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
CopyrightCopyright © 2020 Elsevier Ltd. All rights reserved.
Chemical References
  • Glucosylceramidase
Topics
  • Aged
  • Aged, 80 and over
  • Female
  • Genetic Predisposition to Disease (genetics)
  • Genome-Wide Association Study
  • Genotype
  • Glucosylceramidase (genetics)
  • Humans
  • Lewy Body Disease (genetics)
  • Male
  • Middle Aged
  • Multiple System Atrophy (diagnosis, genetics)
  • Mutation (genetics)
  • Parkinsonian Disorders (genetics)
  • Risk

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: